Cargando…

Molecular Epidemiology and Antimicrobial Resistance of Clostridioides difficile in Hospitalized Patients From Mexico

Clostridioides difficile is a global public health problem, which is a primary cause of antibiotic-associated diarrhea in humans. The emergence of hypervirulent and antibiotic-resistant strains is associated with the increased incidence and severity of the disease. There are limited studies on genom...

Descripción completa

Detalles Bibliográficos
Autores principales: Aguilar-Zamora, Emmanuel, Weimer, Bart C., Torres, Roberto C., Gómez-Delgado, Alejandro, Ortiz-Olvera, Nayeli, Aparicio-Ozores, Gerardo, Barbero-Becerra, Varenka J., Torres, Javier, Camorlinga-Ponce, Margarita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960119/
https://www.ncbi.nlm.nih.gov/pubmed/35360652
http://dx.doi.org/10.3389/fmicb.2021.787451
_version_ 1784677319471792128
author Aguilar-Zamora, Emmanuel
Weimer, Bart C.
Torres, Roberto C.
Gómez-Delgado, Alejandro
Ortiz-Olvera, Nayeli
Aparicio-Ozores, Gerardo
Barbero-Becerra, Varenka J.
Torres, Javier
Camorlinga-Ponce, Margarita
author_facet Aguilar-Zamora, Emmanuel
Weimer, Bart C.
Torres, Roberto C.
Gómez-Delgado, Alejandro
Ortiz-Olvera, Nayeli
Aparicio-Ozores, Gerardo
Barbero-Becerra, Varenka J.
Torres, Javier
Camorlinga-Ponce, Margarita
author_sort Aguilar-Zamora, Emmanuel
collection PubMed
description Clostridioides difficile is a global public health problem, which is a primary cause of antibiotic-associated diarrhea in humans. The emergence of hypervirulent and antibiotic-resistant strains is associated with the increased incidence and severity of the disease. There are limited studies on genomic characterization of C. difficile in Latin America. We aimed to learn about the molecular epidemiology and antimicrobial resistance in C. difficile strains from adults and children in hospitals of México. We studied 94 C. difficile isolates from seven hospitals in Mexico City from 2014 to 2018. Whole-genome sequencing (WGS) was used to determine the genotype and examine the toxigenic profiles. Susceptibility to antibiotics was determined by E-test. Multilocus sequence typing (MLST) was used to determine allelic profiles. Results identified 20 different sequence types (ST) in the 94 isolates, mostly clade 2 and clade 1. ST1 was predominant in isolates from adult and children. Toxigenic strains comprised 87.2% of the isolates that were combinations of tcdAB and cdtAB (tcdA+/tcdB+/cdtA+/cdtB+, followed by tcdA+/tcdB+/cdtA−/cdtB−, tcdA−/tcdB+/cdtA−/ cdtB−, and tcdA−/tcdB−/cdtA+/cdtB+). Toxin profiles were more diverse in isolates from children. All 94 isolates were susceptible to metronidazole and vancomycin, whereas a considerable number of isolates were resistant to clindamycin, fluroquinolones, rifampicin, meropenem, and linezolid. Multidrug-resistant isolates (≥3 antibiotics) comprised 65% of the isolates. The correlation between resistant genotypes and phenotypes was evaluated by the kappa test. Mutations in rpoB and rpoC showed moderate concordance with resistance to rifampicin and mutations in fusA substantial concordance with fusidic acid resistance. cfrE, a gene recently described in one Mexican isolate, was present in 65% of strains linezolid resistant, all ST1 organisms. WGS is a powerful tool to genotype and characterize virulence and antibiotic susceptibility patterns.
format Online
Article
Text
id pubmed-8960119
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89601192022-03-30 Molecular Epidemiology and Antimicrobial Resistance of Clostridioides difficile in Hospitalized Patients From Mexico Aguilar-Zamora, Emmanuel Weimer, Bart C. Torres, Roberto C. Gómez-Delgado, Alejandro Ortiz-Olvera, Nayeli Aparicio-Ozores, Gerardo Barbero-Becerra, Varenka J. Torres, Javier Camorlinga-Ponce, Margarita Front Microbiol Microbiology Clostridioides difficile is a global public health problem, which is a primary cause of antibiotic-associated diarrhea in humans. The emergence of hypervirulent and antibiotic-resistant strains is associated with the increased incidence and severity of the disease. There are limited studies on genomic characterization of C. difficile in Latin America. We aimed to learn about the molecular epidemiology and antimicrobial resistance in C. difficile strains from adults and children in hospitals of México. We studied 94 C. difficile isolates from seven hospitals in Mexico City from 2014 to 2018. Whole-genome sequencing (WGS) was used to determine the genotype and examine the toxigenic profiles. Susceptibility to antibiotics was determined by E-test. Multilocus sequence typing (MLST) was used to determine allelic profiles. Results identified 20 different sequence types (ST) in the 94 isolates, mostly clade 2 and clade 1. ST1 was predominant in isolates from adult and children. Toxigenic strains comprised 87.2% of the isolates that were combinations of tcdAB and cdtAB (tcdA+/tcdB+/cdtA+/cdtB+, followed by tcdA+/tcdB+/cdtA−/cdtB−, tcdA−/tcdB+/cdtA−/ cdtB−, and tcdA−/tcdB−/cdtA+/cdtB+). Toxin profiles were more diverse in isolates from children. All 94 isolates were susceptible to metronidazole and vancomycin, whereas a considerable number of isolates were resistant to clindamycin, fluroquinolones, rifampicin, meropenem, and linezolid. Multidrug-resistant isolates (≥3 antibiotics) comprised 65% of the isolates. The correlation between resistant genotypes and phenotypes was evaluated by the kappa test. Mutations in rpoB and rpoC showed moderate concordance with resistance to rifampicin and mutations in fusA substantial concordance with fusidic acid resistance. cfrE, a gene recently described in one Mexican isolate, was present in 65% of strains linezolid resistant, all ST1 organisms. WGS is a powerful tool to genotype and characterize virulence and antibiotic susceptibility patterns. Frontiers Media S.A. 2022-03-10 /pmc/articles/PMC8960119/ /pubmed/35360652 http://dx.doi.org/10.3389/fmicb.2021.787451 Text en Copyright © 2022 Aguilar-Zamora, Weimer, Torres, Gómez-Delgado, Ortiz-Olvera, Aparicio-Ozores, Barbero-Becerra, Torres and Camorlinga-Ponce. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Aguilar-Zamora, Emmanuel
Weimer, Bart C.
Torres, Roberto C.
Gómez-Delgado, Alejandro
Ortiz-Olvera, Nayeli
Aparicio-Ozores, Gerardo
Barbero-Becerra, Varenka J.
Torres, Javier
Camorlinga-Ponce, Margarita
Molecular Epidemiology and Antimicrobial Resistance of Clostridioides difficile in Hospitalized Patients From Mexico
title Molecular Epidemiology and Antimicrobial Resistance of Clostridioides difficile in Hospitalized Patients From Mexico
title_full Molecular Epidemiology and Antimicrobial Resistance of Clostridioides difficile in Hospitalized Patients From Mexico
title_fullStr Molecular Epidemiology and Antimicrobial Resistance of Clostridioides difficile in Hospitalized Patients From Mexico
title_full_unstemmed Molecular Epidemiology and Antimicrobial Resistance of Clostridioides difficile in Hospitalized Patients From Mexico
title_short Molecular Epidemiology and Antimicrobial Resistance of Clostridioides difficile in Hospitalized Patients From Mexico
title_sort molecular epidemiology and antimicrobial resistance of clostridioides difficile in hospitalized patients from mexico
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960119/
https://www.ncbi.nlm.nih.gov/pubmed/35360652
http://dx.doi.org/10.3389/fmicb.2021.787451
work_keys_str_mv AT aguilarzamoraemmanuel molecularepidemiologyandantimicrobialresistanceofclostridioidesdifficileinhospitalizedpatientsfrommexico
AT weimerbartc molecularepidemiologyandantimicrobialresistanceofclostridioidesdifficileinhospitalizedpatientsfrommexico
AT torresrobertoc molecularepidemiologyandantimicrobialresistanceofclostridioidesdifficileinhospitalizedpatientsfrommexico
AT gomezdelgadoalejandro molecularepidemiologyandantimicrobialresistanceofclostridioidesdifficileinhospitalizedpatientsfrommexico
AT ortizolveranayeli molecularepidemiologyandantimicrobialresistanceofclostridioidesdifficileinhospitalizedpatientsfrommexico
AT aparicioozoresgerardo molecularepidemiologyandantimicrobialresistanceofclostridioidesdifficileinhospitalizedpatientsfrommexico
AT barberobecerravarenkaj molecularepidemiologyandantimicrobialresistanceofclostridioidesdifficileinhospitalizedpatientsfrommexico
AT torresjavier molecularepidemiologyandantimicrobialresistanceofclostridioidesdifficileinhospitalizedpatientsfrommexico
AT camorlingaponcemargarita molecularepidemiologyandantimicrobialresistanceofclostridioidesdifficileinhospitalizedpatientsfrommexico